Actinium Pharmaceuticals, Inc. (ATNM)
Equity Ratio
75.46%
Quarterly · Period ending:
ATNM Equity Ratio
Latest reported75.46%period ending
Latest reported75.46%period ending
ATNM Quarterly Equity Ratio (-3949.36% → 75.46%)
Latest values, visible window
High-resolution chart · PNG
ATNM equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 75.4588% | |
| 5.0706% | |
| 15.1309% | |
| 24.5481% | |
| 30.1712% | |
| 37.4292% | |
| 42.5987% | |
| 46.5304% | |
| 48.7809% | |
| 49.6389% | |
| 44.667% | |
| 49.0005% | |
| 53.5855% | |
| 56.072% | |
| 58.2186% | |
| 60.9976% | |
| 64.188% | |
| 92.3218% | |
| 91.4875% | |
| 95.0355% | |
| 95.317% | |
| 94.1928% | |
| 92.3521% | |
| 89.9064% | |
| 90.7359% | |
| 36.1071% | |
| 48.3633% | |
| 60.8894% | |
| 71.9582% | |
| 43.6672% | |
| 59.1884% | |
| 73.7477% | |
| 76.6822% | |
| 77.2815% | |
| 74.5543% | |
| 83.7517% | |
| 68.3582% | |
| 70.568% | |
| 79.9344% | |
| 82.4596% | |
| 88.4647% | |
| 85.9238% | |
| 82.6478% | |
| 91.3959% | |
| 88.4129% | |
| 81.9963% | |
| -25.3998% | |
| 18.827% | |
| 28.0321% | |
| -205.31% | |
| -27.0488% | |
| 14.9217% | |
| 33.3913% | |
| 16.4076% | |
| 19.7905% | |
| -3.6738% | |
| -70,616.9014% | |
| -62,637.3333% | |
| -56,219.3333% | |
| -54,454.6667% | |
| -52,112% | |
| -65,748% | |
| -63,078.6667% | |
| -57,397.3333% | |
| -217.9358% | |
| -8,730.217% | |
| -4,537.7945% | |
| -4,044.4548% | |
| -3,822.3502% | |
| -3,613.2179% | |
| -3,334.5807% | |
| -2,959.3666% | |
| -2,781.068% | |
| -2,338.2096% | |
| -516.1511% | |
| -444.1387% | |
| -4,766.9528% | |
| -3,949.3562% | |
| -3,949.3562% |